Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd.

Clinical trials sponsored by Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd., explained in plain language.

Trials to join now! 4 Not yet finished but already full! 1

New hope for psoriasis patients when standard treatments fail

Disease control Ongoing

This study tests a new medicine called picankibart for people with plaque psoriasis who did not get good results from standard IL-17 antibody treatments. About 310 adults in China will receive either picankibart or an active control to see if switching helps clear skin and reduce…

Phase: PHASE3 • Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. • Aim: Disease control

Last updated May 07, 2026 18:43 UTC